News Room

Follow:
48001 Articles

Protara: Treatment Data Bodes Well For Mid-2025 Catalyst

This article was written byFollowTerry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his

US judge blocks $25bn Kroger-Albertsons grocery merger

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.The largest

Walgreens Boots in talks over sale to private equity group Sycamore Partners

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.US-based pharmacy

Benjamin Netanyahu decries ‘libel and lies’ in first corruption trial testimony

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.A defiant

Russian forces stay put at key military bases in Syria

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Russia is

China’s CATL to build $4.3bn battery factory with Stellantis in European expansion

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.CATL and

Iran and the onset of a Trumpian world

Unlock the White House Watch newsletter for freeYour guide to what the 2024 US election means for Washington and the

Wall Street’s complex debt bonanza hits fastest pace since 2007

Stay informed with free updatesSimply sign up to the Financial services myFT Digest -- delivered directly to your inbox.Investors’ “relentless”

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.